DDrare: Database of Drug Development for Rare Diseases

Granulocyte colony stimulating factor (gcsf) (DrugBank: Granulocyte Colony Stimulating Factor)

2 diseases

ID	Disease name (Link within this page)	Number of trials
36	Epidermolysis bullosa	1
57	Idiopathic dilated cardiomyopathy	1

36. Epidermolysis bullosa [ 147 clinical trials, 170 drugs, (DrugBank: 40 drugs), 32 drug target genes, 113 drug target pathways]

Searched query = "Epidermolysis bullosa", "EBS", "JEB", "DDEB", "RDEB", "Kindler syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 147 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01538862 (ClinicalTrials.gov)	February 2012	20/2/2012	Efficacy of Granulocyte Colony Stimulating Factor (GCSF) In Patients With Dystrophic Epidermolysis Bullosa	Efficacy of Granulocyte Colony Stimulating Factor (GCSF) In Patients With Dystrophic Epidermolysis Bullosa	Dystrophic Epidermolysis Bullosa	Drug: Granulocyte Colony Stimulating Factor (GCSF)	Vanderbilt University Medical Center	NULL	Completed	N/A	N/A	All	7	Phase 2	United States

57. Idiopathic dilated cardiomyopathy [ 12 clinical trials, 25 drugs, (DrugBank: 12 drugs), 9 drug target genes, 33 drug target pathways]

Searched query = "Idiopathic dilated cardiomyopathy"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 12 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01302171 (ClinicalTrials.gov)	August 2010	21/2/2011	Bone Marrow Derived Adult Stem Cells for Dilated Cardiomyopathy	Randomised Controlled Trial to Compare the Effects of G-CSF (Granocyte™) and Autologous Bone Marrow Progenitor Cells on Quality of Life and Left Ventricular Function in Patients With Idiopathic Dilated Cardiomyopathy	Dilated Cardiomyopathy	Drug: granulocyte colony stimulating factor (GCSF);Procedure: bone marrow mononuclear cells	Barts & The London NHS Trust	Royal Brompton & Harefield NHS Foundation Trust;University College London Hospitals	Completed	18 Years	80 Years	Both	60	Phase 2	United Kingdom